No description
-
2009 (v1)PublicationUploaded on: March 31, 2023
-
2011 (v1)Publication
We report that somatostatin receptor (SSTR) 1,2 and 5 activation by selective agonists, causes C6 cell growth arrest through PTPh-dependent dephosphorylation of ERK1/2 in vitro and after xenografting in nude mice. Individual SSTR agonists displayed different effi cacy and potency showing partial synergism by combined treatment. Since most tumor...
Uploaded on: March 31, 2023 -
2013 (v1)Publication
Here, we present a minimal hybrid ligand/receptor-based pharmacophore model (PM) for CXCR4, a chemokine receptor deeply involved in several pathologies, such as HIV infection, rheumatoid arthritis, cancer development/progression, and metastasization. This model, considerably simpler than those thus far proposed for this receptor, has been used...
Uploaded on: April 14, 2023 -
2008 (v1)Publication
Somatostatin inhibits cell proliferation through the activation of five receptors (SSTR1-5) expressed in normal and cancer cells. We analyzed the role of individual SSTRs in the antiproliferative activity of somatostatin in C6 rat glioma cells. Somatostatin dose-dependently inhibited C6 proliferation, an effect mimicked, with different efficacy...
Uploaded on: March 27, 2023 -
2013 (v1)Publication
Cancer stem cells (CSCs) or tumor initiating cells (TICs) drive glioblastoma (GBM) development, invasiveness and drug resistance. Distinct molecular pathways might regulate CSC biology as compared to cells in the bulk tumor mass, representing potential therapeutic targets. Chemokine CXCL12 and its receptor CXCR4 control proliferation, invasion...
Uploaded on: April 14, 2023 -
2016 (v1)Publication
Human reproductive failure is a frequent and multifactorial event. Emerging evidence involved endometrial dysfunction in implantation failure and recurrent pregnancy loss, highlighting the central role of endometrium in reproductive success. In this context it was demonstrated that human endometrial stromal cells are essential for endometrial...
Uploaded on: April 14, 2023 -
2011 (v1)Publication
Malignant pleural mesothelioma (MPM) is an aggressive chemotherapy-resistant cancer. Up-regulation of epidermal growth factor receptor (EGFR) plays an important role in MPM development and EGFRtyrosine kinase inhibitors (TKIs) may represent novel therapeutic options. We tested the effects of the EGFR TKIs gefitinib and erlotinib and TKIs...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
Glioblastoma (GBM), the most common primary brain tumor in adults, is an aggressive, fast-growing and highly vascularized tumor, characterized by extensive invasiveness and local recurrence. In GBM and other malignancies, cancer stem cells (CSCs) are believed to drive invasive tumor growth and recurrence, being responsible for radio- and...
Uploaded on: March 27, 2023 -
2011 (v1)Publication
CXCR4 and CXCR7 chemokine receptors, and their ligands CXCL11 and CXCL12, have been often involved in tumor cell proliferation and survival. We report the expression pattern of these ligand/receptor pairs in 22 human meningiomas. High CXCR7 and CXCL12 expression was associated with high-proliferative tumors. CXCR7 levels were correlated to the...
Uploaded on: April 14, 2023 -
2015 (v1)Publication
Glioblastoma multiforme is a highly aggressive brain tumor whose prognosis is very poor. Due to early invasion of brain parenchyma, its complete surgical removal is nearly impossible, and even after aggressive combined treatment (association of surgery and chemo- and radio-therapy) five-year survival is only about 10%. Natural products are...
Uploaded on: March 27, 2023